CV (until May 2008)
CV (until May 2008)
CV (until May 2008)
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
<strong>CV</strong>: Davood Beiki<br />
Friday, 30 <strong>May</strong> <strong>2008</strong><br />
Home<br />
<strong>CV</strong><br />
Back to TUMS website<br />
Davood Beiki Persian<br />
<strong>CV</strong><br />
Academi Rank: Associate Professor<br />
School: Medicine<br />
Department: Nuclear medicine<br />
Hospital/Ward: Shariati/Nuclear medicine<br />
Research Center: Research Institute for Nuclear Medicine<br />
Address: Research Institute for Nuclear Medicine, Shariati Hospital, North Kargar Ave.,<br />
14117-13135 Tehran, Iran<br />
Tel: 88633333<br />
Fax: 88026905<br />
Email: beikidav@sina.tums.ac.ir<br />
Website: http://www.tums.ac.ir/faculties/?facultyID=147<br />
<strong>CV</strong> last edited on: 10 <strong>May</strong> <strong>2008</strong><br />
Print-Friendly Version<br />
Education<br />
Education:<br />
1- High School Certificate: 1989<br />
2- Tehran University of Medical Sciences, Iran, Doctor of Pharmacy (Pharm.D.) 1989-1995.<br />
Thesis :Comparative bioavailability of two tablet formulation of dipyridamole in healthy male volunteers.<br />
Supervisor:Professor A. Shafiee<br />
3-Tehran University of Medical Sciences, Iran, PhD (Nuclear Pharmacy) 1995-1999.<br />
Thesis: Tumor Imaging Agents: 1-Synthesis of tissue hypoxia Markers, 2- Radioiodination of antibodies.<br />
Supervisor:Professor A. Khalaj<br />
4 -Faculty<br />
of Pharmacy and Pharmaceutical Sciences, University of Alberta, Canada, Postdoctoral fellowship<br />
in Radiochemistry, November 1999- <strong>May</strong> 2000.<br />
5- Present Title: Associate Professor.<br />
Positions Held<br />
1- Associate Professor of Nuclear Pharmacy, Research Institute for Nuclear Medicine, Faculty of Medicine,<br />
Tehran University of Medical Sciences<br />
Page 1 of 18<br />
2- Deputy for Research, Research Institute for Nuclear Medicine, Tehran University of Medical Sciences,<br />
(Since 2001).<br />
Experiences<br />
Workshops:<br />
1- Radiation Safety Course, Radiation Control Committee, University of Alberta, Canada, 3-8 February<br />
2000.<br />
2- Research Methodology, Institute of Public Health Researches, Tehran University of Medical<br />
Sciences, Tehran, Iran, 18-25 October, 2003.<br />
3- Reference Manager Software, Faculty of Medicine, Tehran University of Medical Sciences, Tehran,<br />
Iran, 18-20 September, 2005.<br />
4- EndNote Software, Faculty of Medicine, Tehran University of Medical Sciences, Tehran, Iran, 22-23<br />
December, 2005.<br />
mhtml:file://C:\Documents and Settings\Dr\Desktop\<strong>CV</strong> Davood Beiki.mht<br />
<strong>2008</strong>/05/30
<strong>CV</strong>: Davood Beiki<br />
5- Scientific writing, Faculty of Medicine, Tehran University of Medical Sciences, Tehran, Iran, 23<br />
February, 2006.<br />
6- Radiopharmaceuticals Quality Control, Radioisotope Department, Nuclear Research Center, Atomic<br />
Energy Organization of Iran (AEOI), Tehran, Iran, 11-15 March 2006.<br />
7- SPSS Software, Faculty of Medicine, Tehran University of Medical Sciences, Tehran, Iran, 30-31<br />
<strong>May</strong>, 2006.<br />
Reviewer of Journals:<br />
1- Applied Radiation and Isotopes<br />
2- Iranian Journal of Nuclear Medicine, Iran<br />
3- Mazandaran University of Medical Sciences Journal, Iran<br />
4- Journal of Nuclear Sciences and Technology, Iran<br />
5- Tehran University Medical Journal, Iran<br />
6- Daru, Iran<br />
Honors, Distinctions, and Scientific Societies Membership<br />
Social & Scientific Activity:<br />
Member of Iranian Medical Council<br />
Member of Iranian Association of Pharmacists<br />
Member of Iranian Society of Nuclear Medicine<br />
Member of American Society of Nuclear Medicine<br />
Member of European Association of Nuclear Medicine<br />
Member of Radiopharmacy National Board of Examination<br />
Member of Nuclear Medicine National Board of Examination<br />
Member of Editorial Board, Iranian Journal of Nuclear Medicine<br />
Awards:<br />
1- Razi Award for the young researcher in basic Sciences, Razi International Festival of Medical Sciences in<br />
Research, Tehran, Iran (2003).<br />
2- Avicenna Award (Tehran University of Medical Sciences) for the young researcher, Tehran, Iran (2003).<br />
3- ARS Maurice H. Cottle Award, 51st Annual Meeting of the American Rhinologic Society, Los Angeles,<br />
California, USA (2005)<br />
4- Razi Award for the foundations advocating medical sciences researches, Razi International Festival of<br />
Medical Sciences in Research, Tehran, Iran (2005).<br />
Language Skills<br />
Persian (Farsi) & English<br />
Computer Knowledge<br />
Microsoft Word - Powerpoint - SPSS - EndNote - Reference Manager<br />
English Publications<br />
A. Papers in Journals<br />
1. Beiki D., Pirali M., Amini M., Shafiee A., “High performance liquid<br />
chromatographic method for determination of dipyridamole in human plasma”,<br />
DARU, 1999; 7(2): 14-17. [English]<br />
2. Khalaj A., Beiki D., Rafiee H., Najafi R., “A new and simple synthesis of Nsuccinimidyl-4-[<br />
125I]iodobenzoate involving a microwave-accelerated<br />
iodination step”, Journal of Labelled Compounds &<br />
Radiopharmaceuticals, 2001; 44: 235-240. [English]<br />
3. Beiki D., Shahhosseini S., Khalaj A., Eftekhari M., “Increased selectivity in<br />
inflammatory site identification via labelling of IgG with N-succinimidyl-4-<br />
[ 125I]iodobenzoate”, Journal of Labelled Compounds &<br />
Radiopharmaceuticals, 2002; 45: 235-240. [English]<br />
4. Kumar P. Wiebe LI, Beiki D., Ohkura K., Seki KI, “Synthesis of β-azomycin<br />
nucleosides: 1-(β-D-2-iodo-2-deoxyarabinofuranosyl)-2-nitroimidazole, a<br />
novel marker of tissue hypoxia, Tetrahedron Letters, 2002; 43: 4427-<br />
4429. [English]<br />
5. Beiki D., Shahhosseini S., Khalaj A., Eftekhari M., Rafiee H. “Reduction of<br />
in vivo deiodination of radioiodinated of antibodies using N-succinimidyl-4-<br />
[ 125I]iodobenzoate”, Iranian Journal of Nuclear Medicine, 2002; 18:<br />
21-26. [English]<br />
6. Kumar P., Ohkura K., Beiki D., Wiebe LI, Seki KI, “Synthesis of 1-β-D-(5deoxy-5-iodoarabinofuranosyl)-2-nitroimidazole<br />
(β-IAZA): a novel marker<br />
of tissue hypoxia”, Chem. Pharm. Bull. 2003; 51(4): 399-403.<br />
mhtml:file://C:\Documents and Settings\Dr\Desktop\<strong>CV</strong> Davood Beiki.mht<br />
Page 2 of 18<br />
<strong>2008</strong>/05/30
<strong>CV</strong>: Davood Beiki<br />
[English]<br />
7. Matloobi M., Rafii H., Beiki D., Khalaj A., Kamali-Dehghan M.,“ Synthesis<br />
of radioiodinated labeled peptides”, Journal of Radioanalytical and<br />
Nuclear Chemistry 2003; 257(1): 71-73. [English]<br />
8. Beiki D., Shahhosseini S., Eftekhari M., Takavar A. “Contamination<br />
monitoring of Na 131I level in therapy unit of Research Institute for Nuclear<br />
Medicine, Tehran University of Medical Sciences, by indirect method (wipe<br />
test)”, Iranian Journal of Nuclear Medicine, 2003; 19: 9-16. [Persian]<br />
9. Beiki D., Amini M., Dowlatabadi R., Pirali M. “Comparative bioavailability of<br />
two tablet formulation of dipyridamole in healthy male volunteers”,<br />
Iranian Journal of Pharmaceutical Research, 2003; 2: 213-216.<br />
[English]<br />
10. 10. Fard-Esfahani A., Olamaei R., Eftekhari M., Saghari M. and Beiki D.<br />
“Radioiodine therapy effects on salivaroy gland function in patients with<br />
differentiated thyroid cancer”, Iranian Journal of Nuclear Medicine,<br />
2003; 19: 17-22. [Persian]<br />
11. 11. Shahosseini S., Beiki D., Eftekhari M. “Gamma-scintigraphy in the<br />
evaluation of drug delivery systems", Iranian Journal of Nuclear<br />
Medicine, 2003; 20: 26-38. [Persian]<br />
12. 12. Eftekhari M., Olamaei R., Fard A., Beiki D., Saghari M. “ 131I-MIBG scintigraphy in carcinoid tumor with liver metastases”, Iranian Journal of<br />
Nuclear Medicine, 2003; 20:7-12. [Persian]<br />
13. Eftekhari M., Takavar A.,Ansari-Gilani K., Akhzari F., Fard A., Beiki D., “<br />
Effects of treatment with radioiodine ( 131I) on the gonadal function of the<br />
hyperthyroid patients”, Iranian Journal of Nuclear Medicine, 2003; 20:<br />
7-12. [English]<br />
14. Takavar A., Eftekhari M., Beiki D., Saghari M., Mostaghim M., Sohrabi M. “<br />
Qualitative evaluation of Chang method of attenuation correction on heart<br />
SPECT by using custom made heart phantom”, Iranian Journal of<br />
Nuclear Medicine, 2003; 20: 13-17. [English]<br />
15. Beiki D., Shahhosseini S., Dadashzadeh S., Eftekhari M., Tayebi H.,<br />
Moosazadeh-Rashti G. “ Determination of radiation dose rates and urinary<br />
activity of patients received sodium iodide-131 for treatment of<br />
differentiated thyroid carcinoma”, Iranian Journal of Nuclear Medicine,<br />
2004; 21: 1-14. [Persian]<br />
16. Saghari M., Fallahi B., Eftekhari M., Iravani M., Izadyar S., Esmaili J., Beiki<br />
D., Fard A. “ Value of 99mTc-Mibi scintigraphy in active disease and<br />
remission phase of multiple myeloma”, Iranian Journal of Nuclear<br />
Medicine, 2004; 21: 15-24. [Persian]<br />
17. Eftekhari M., Sadeghi R., Fard A., Beiki D., Fallahi B., Saghari M.,<br />
“Reverse re-distribution in myocardial perfusion scan with 201Tl”, Iranian<br />
Journal of Nuclear Medicine, 2004; 21: 25-32. [Persian]<br />
18. Eftekhari M., Assadi M., Fard-Esfehani A., Beiki D., and Fallahi B.<br />
“Dystrophic calcinosis cutis and SLE; the bone scan pattern (Case report)”,<br />
Iranian Journal of Nuclear Medicine, 2004; 22: 1-4. [Persian]<br />
19. Fard-Esfehani A., Eftekhari M., Aliyari N., Saghari M., Beiki D. “Effects of<br />
treatment with radioactive iodine on gonadal functions in patients with<br />
differentiated thyroid cancer”, Tehran University Medical Journal ,<br />
2004; 62(1): 31-36. [Persian]<br />
20. Fard A., Emami F., Eftekhari M., Saghari M., Fallahi B., Beiki D., and<br />
Takavar A. “The value of myocardial perfusion imaging in differentiating<br />
between idiopathic dilated cardiomyopathy from the ischemic form”,<br />
Iranian Journal of Nuclear Medicine, 2004; 22: 15-20. [Persian]<br />
21. Shahhosseini S., Beiki D., Dadashzadeh S., Eftekhari M., Tayebi H.,<br />
Moosazadeh G. “Radiation dose rate and urinary activity in patients with<br />
differentiated thyroid carcinoma treated with radioiodine-131; a survey in<br />
Iranian population”, Hellenic Journal of Nuclear Medicine, 2004; 7(3):<br />
192-194. [English]<br />
22. Fard A., Fallahi B., Olamaei R., Eftekhari M., Beiki D., Saghari M., “Semiquantitative<br />
assessment of salivary gland function in patients with<br />
mhtml:file://C:\Documents and Settings\Dr\Desktop\<strong>CV</strong> Davood Beiki.mht<br />
Page 3 of 18<br />
<strong>2008</strong>/05/30
<strong>CV</strong>: Davood Beiki<br />
differentiated thyroid carcinoma after radioiodine-131 treatment”, Hellenic<br />
Journal of Nuclear Medicine, 2004; 7(3): 206-209. [English]<br />
23. Dowlatabadi R., Khalaj A., Beiki D., Eftekhari M., Al-Seyed Hosein M.H.,<br />
Khoshayand M.R., “Microdose 14C Urea breath test for the diagnosis of<br />
Helicobacter Pylori: a survey in Iranian population”, DARU, 2005; 13(1):<br />
6-10. [English]<br />
24. Beiki D., Khalaj A., Dowlatabadi R., Eftekhari M., Al-Seyed Hosein M.H.,<br />
Khoshayand M.R., Fard A., Fallahi B., Khoshayand M.R., “Validation of 13C urea breath test with non dispersive isotope selective infrared spectroscopy<br />
for the diagnosis of Helicobacter pylori infection: a survey in Iranian<br />
population”, DARU, 2005; 13(2): 52-55.[English]<br />
25. Dowlatabadi R., Beiki D., Khalaj A. “Radiopharmaceutical regulation world<br />
wide - the resemblances and the differences”, Iranian Journal of<br />
Nuclear Medicine, 2005; 23: 1-13. [Persian]<br />
26. Saghari M., Moslehi M., Esmaeili J., Tahmasebi M.N., Radmehr A., Eftekhari<br />
M., Fard-Esfahani A., Beiki D., Fallahi B., Gholamrezanezhad A. “Accuracy<br />
of SPECT bone scintigraphy in diagnosis of meniscal tears”, Iranian<br />
Journal of Nuclear Medicine, 2005; 23: 1-6. [English]<br />
27. Beiki O., Beiki D., “Parsmedline: establishment of a web-based<br />
bibliographic database related to Iranian health and medical research”,<br />
Journal of Medical Library Association, 2005 July; 93(3):400-403.<br />
[English]<br />
28. Avadi M.R., Ghassemi A.H., Sadeghi A.M.M., Beiki D., Akbarzadeh A.,<br />
Ebrahimnejad P., Shahhosseini S., Bayati K.H., Rafiiee-Tehrani M.<br />
“Gammascintigraphy evaluation of enteric-coated capsules containing<br />
chitosan-brilliant blue gel beads as hydrophilic model for colon drug<br />
delivery”, Journal of Drug Delivery Science and Technology, 2005;<br />
15(5):383-387. [English]<br />
29. Fard A., Dabbagh V.R., Fallahi B., Eftekhari M., Beiki D., Saghari M.,<br />
Takavar A. “Comparative evaluation of two fixed doses of 185 and 370 MBq<br />
131I, for the treatment of Graves' disease resistant to antithyroid drugs”,<br />
Hellenic Journal of Nuclear Medicine, 2005; 8(3): 165-168. [English]<br />
30. 30. Fallahi B., Saghari M., Fard A., Eftekhari M., Iravani M., Beiki D.,<br />
Dabbagh V.R., Sadeghi R. “The value of 99mTc-MIBI whole body<br />
scintigraphy in active and in remission multiple myeloma”, Hellenic<br />
Journal of Nuclear Medicine, 2005; 8(3): 158-161. [English]<br />
31. Gholamrezanezhad A., Eftekhari M., Fard A., Fallahi B., Beiki D.,<br />
“Unilateral absent lung ventilation and perfusion due to hilar mass”,<br />
Hellenic Journal of Nuclear Medicine, 2005; 8(3): 169-170. [English]<br />
32. Fard Esfahani A., Akhzari F., Mirshekarpour H., Saghari M., Izadyar S.,<br />
Esmaili J., Fallahi B., Beiki D., “Radioiodine treatment effects on lacrimal<br />
glands function in patients with thyroid cancer”, Iranian Journal of<br />
Nuclear Medicine, 2005; 13(24): 6-14. [Persian]<br />
33. Eftekhari M., Saghari M., Noorani M. H., Fard-Esfahani A., Beiki D., Fallahi<br />
B., “Evaluation of diagnostic role of 99mTc-Tetrofosmin scintigraphy in cold<br />
thyroid nodules”, Iranian Journal of Nuclear Medicine, 2005; 13(24):<br />
15-24. [Persian]<br />
34. Eftekhari M, Assadi M, Kazemi M, Saghari M, Fard-Esfahani A, Fallahi<br />
Sichani B, Gholamrezanezhad A, Beiki D., “A preliminary study of<br />
neuroSPECT evaluation of patients with posttraumatic smell impairment”,<br />
BMC Nuclear Medicine, 2005; 5(6): doi;10.1186-1471-2385-5-6.<br />
[English]<br />
35. Fard-Esfahani A., Assadi M., Saghari M., Eftekhari M., Fallahi Sichani B.,<br />
Beiki D., Akbarpour S., Mohammadian B., “Myocardial 99mTc-MDP uptake<br />
on the bone scintigraphy in the hemodialysis-associated amyloidosis: A<br />
case report”, Iranian Journal of Nuclear Medicine, 2005; 13(24): 1-5.<br />
[Persian]<br />
36. Saghari M., Assadi M., Eftekhari M., Yaghoubi M., Fard-Esfahani A.,<br />
Malekzadeh J., Fallahi B, Beiki D., Takavar A. "Frequency and severity of<br />
myocardial perfusion abnormalities using Tc-99m-MIBI SPECT in cardiac<br />
mhtml:file://C:\Documents and Settings\Dr\Desktop\<strong>CV</strong> Davood Beiki.mht<br />
Page 4 of 18<br />
<strong>2008</strong>/05/30
<strong>CV</strong>: Davood Beiki<br />
syndrome X", BMC Nucl Med 2006; 6: 1 DOI: 10.1186/1471-2385-6-<br />
1. [English]<br />
37. Gholamrezanezhad A., Moinian D., Eftekhari M., Beiki D. "The prevalence<br />
and significance of increased gastric wall radiotracer uptake in sestamibi<br />
myocardial perfusion SPECT", Int J Cardiovas Imag 2006; 6: 1 DOI<br />
10.1007/s10554-005-9055-6. [English]<br />
38. Saghari M, Gholamrezanezhad A, Mirpour S, Eftekhari M, Takavar A, Fard-<br />
Esfahani A, Fallahi B, Beiki D. "Efficacy of radioiodine therapy in the<br />
treatment of elevated serum thyroglobulin in patients with differentiated<br />
thyroid carcinoma and negative whole-body iodine scan", Nucl Med<br />
Commun 2006 Jul; 27(7):567-72. [English]<br />
39. Fallahi B., Beiki D., Assadi M., Fard-Esfahani A, "Thallium-201 single<br />
photon emission tomography after injecting an antimuscarinic agent<br />
compared with computed tomography for the diagnosis of recurrent<br />
colorectal cancer: Report of three cases", Hellenic Journal of Nuclear<br />
Medicine, 2006; 9(2): 106-108. [English]<br />
40. Eftekhari M., Gholamrezanezhad A., Izadyar S., Esmaili J., Mirpour S.,<br />
Saghari M., Fard-Esfahani A., Fallahi Sichani B., Beiki D., “Catheter related<br />
artifacts on bone scanes: report of two cases”, Iranian Journal of<br />
Nuclear Medicine, 2006; 14(25): 21-25. [English]<br />
41. Eftekhari M., Assadi M., Kazemi M., Saghari M., Mojtahedi A., Fard-Esfahani A.,<br />
Sichani BF., Beiki D., “Brain perfusion single photon emission computed<br />
tomography findings in patients with posttraumatic anosmia and<br />
comparison with radiological imaging”, American Journal of Rhinology,<br />
2006; 20(6): 577-81. [English]<br />
42. Fard-Esfahani A., Fallahi B., Khatami K., Eftekhari M., Saghari M., Beiki D.,<br />
Ansari-Gilani K., Takavar A., “Agreement of two methods of planar and<br />
SPECT scintigraphy with 99mTc-RBC in detection of liver hemangioma”,<br />
Iranian Journal of Nuclear Medicine, 2006; 14(26): 8-12. [Persian]<br />
43. Gholamrezanezhad A., Mirpour S., Esfahani AF., Saghari M., Mirpour K.,<br />
Beiki D., Soheilifar M., “A correlative study comparing current different<br />
methods of calculating left ventricular ejection fraction”, Nucl Med<br />
Commun 2007; 28(1):41-48. [English]<br />
44. Gholamrezanezhad A., Saghari M., Mirpour S., Beiki D., Javan S.,<br />
Abdollahzadeh J., “On-levothyroxine measurement of thyroglobulin is not a<br />
reliable test for the follow-up of patients at high risk for remnant/recurrent<br />
differentiated thyroid carcinoma”, Pol J Endocrinol 2007; 58(2): 100-<br />
104. [English]<br />
45. Beiki D., Gholamrezanezhad A., Mirpour S., Fallahi B., Saghari M.,<br />
Eftekhari M., Fard-Esfahani A., Hajimahmoudi H., “The relationship<br />
between dyspepsia and increased radiotracer uptake in the gastric wall<br />
during 99mTc-MIBI myocardial perfusion imaging”, J Mazandaran Univ<br />
Med Sci 2007; 16(56): 1-8 [Persian]<br />
46. Fard-Esfahani A., Fallahi B., Saghari M., Eftekhari M., Beiki D., “Myocardial<br />
Perfusion Scan Accuracy in Detection of Coronary Artery Disease -<br />
Comparison with Exercise Stress Test”, Iranian Journal of Nuclear<br />
Medicine, 2007; 15(27): 16-23. [Persian]<br />
47. Fard-Esfahani A., Mirshekarpour H., Fallahi B., Eftekhari M., Saghari M.,<br />
Beiki D., Ansari-Gilani K., Takavar A., “The effect of high-dose radioiodine<br />
treatment on lacrimal gland function in patients with differentiated thyroid<br />
carcinoma”, Clin Nucl Med. 2007; 32(9): 696-9. [English]<br />
48. Gholamrezanezhad A, Fard-Esfahani A, Sadeghi-Tari A, Mirpour S, Saghari<br />
M, Eftekhari M, Fallahi B, Beiki D, Poormoslemi A, Tarbiat A., "Quantitative<br />
assessment of dacryoscintigraphic images in the evaluation of epiphora",<br />
Orbit. 2007 Dec;26(4):229-35. [English]<br />
49. Gholamrezanezhad A, Bagheri M, Mohammadnezhad M, Mirpour S, Majd<br />
Ardekani J, Alimoghadam K, Bashtar M, Beiki D, Ansari Gilani K, Saghari<br />
M, Ghavamzadeh A, Malekzadeh R., " The First Experience of Stem Cell<br />
Labeling in Iran Using 111In- Oxine", Iran J Nucl Med 2007; 15(2):25-<br />
27. [Persian]<br />
mhtml:file://C:\Documents and Settings\Dr\Desktop\<strong>CV</strong> Davood Beiki.mht<br />
Page 5 of 18<br />
<strong>2008</strong>/05/30
<strong>CV</strong>: Davood Beiki<br />
50. Beiki D., Eftekhari M., Fallahi B., Gheisari F., Hozhabrosadati M., Fard-Esfahani A.,<br />
Takavar A., Gholamrezanezhad A., Saghari M. Ansari Gilani K."Comparative<br />
scintigraphic study of renal function with 99mTc-Mercaptoacetyl-triglycine and 99mTc- Ethylenedicysteine", DARU <strong>2008</strong>; 16(1):41-46. [English]<br />
B. Abstracts in National and International Congress<br />
1. Beiki D., Shafiee A., Amini M. “A HPLC method for evaluation of bioavailability of<br />
generic dipyridamole tablets”, Second Iranian Seminar of Pharmacy<br />
Students, Mashhad University of Medical Sciences, Mashhad, Iran, 21-<br />
22 Oct. 1995.<br />
2. Beiki D., Khalaj A., Rafiee H., Najafi R., “Synthesis of radioiodinated of Nsuccinimidyl-4-idobenzoate<br />
for the radiohalogenation of proteins resulting in<br />
decreased thyroid uptake of radioiodine”, 7th Iranian Organic Chemistry<br />
Conferences, University of Tehran, 12-13 Sept. 1999.<br />
3. Beiki D., Kumar P., Wiebe LI, “Synthesis and radiohalogenation of 2’-IAZA, a<br />
potential analog of IAZA, as a novel radiotracer for imaging tissue hypoxia”,<br />
AFPC Conferences 2000, Saskatoon, Canada, 2000.<br />
4. Kumar P., Beiki D., Tandon M., Mc Evans AJB, Wiebe LI, “Microwave-accelerated<br />
radiohalogenation of nitroimidazole-based hypoxia markers”, Fourth<br />
International Symposium on Radiohalogens, Whistler, Canada, Sept. 9-<br />
13, 2000.<br />
5. Rafiee H., Beiki D., Matlubi M et al, “Optimization of synthesis and quality<br />
control procedures for the preparation of I-125-labelled peptides”,<br />
International Atomic Energy Agency, Final Research Co-ordinated<br />
Meeting, Shanghai, China, 30 October to 3 November 2000.<br />
6. Rafiee H., Matlubi M., Beiki D., Khalaj A., Kamali-Dehghan M. “Synthesis of I-<br />
125, I-131 labelled peptides”, 4th International Conference on isotopes,<br />
Capetown, South Africa, 10-14 March, 2002.<br />
7. Beiki D., Khalaj A., Rafiee H., Najafi R., “A novel synthesis of 125I-labelled Nsuccinimidyl-4-idobenzoate<br />
for use in antibody labelling”, 8th Iranian Seminar<br />
of Pharmaceutical Sciences, Shiraz, Iran, 27-29 August, 2002.<br />
8. Shahhosseini S., Beiki D., Khalaj A., Eftekhari M. “Reduction of in vivo<br />
deiodination of radioiodinated of antibodies using N-succinimidyl-4-[ 125I] iodobenzoate”, 8th Congress of The World Federation of Nuclear Medicine<br />
and Biology, Santiago, Chile, 2002.<br />
9. Beiki D., Kumar P., Wiebe LI, “Synthesis of β-2-IAZA, a novel radiotracer of<br />
tissue hypoxia”, The 6th Annual Meeting of Nuclear Medicine, Mashhad,<br />
Iran, 19-21 October, 2002.<br />
10. Shahhosseini S., Beiki D. “Evaluation of new drug delivery systems using<br />
gammascintigraphy”, 1st National Conference on Novel Drug Delivery<br />
Systems, Tehran, Iran, 26-27 February, 2003.<br />
11. Beiki D., Eftekhari M., “Leukocyte radiolabelling with 99mTc-HMPAO for imaging<br />
of inflammation and infection”, The First Congress of Early Detection of<br />
Disease, Hamedan,Iran, <strong>May</strong> 12-15, 2003.<br />
12. Eftekhari M., Takavar A., Ansari K., Fard A., Beiki D. “Effects of treatment with<br />
radioiodine (I-131) on the gonadal function of the hyperthyroid patients.”, 51st Annual Meeting of the Society of Nuclear Medicine, Philadelphia, PA,<br />
USA, June 19-23, 2004.<br />
13. Fallahi B., Iravani M., Saghari M., Beiki D., Eftekhari M., Dabbagh V., Fard A.<br />
“The value of 99mTc-MIBI Scintigraphy in active disease and remission phase of<br />
multiple myeloma.”, 4th National Iranian Congress of Hematology &<br />
Oncology and Nursing Meeting, Mashhad, Iran, June 24-26, 2004.<br />
14. Fard A., Eftekhari M., Fallahi B., Beiki D., Saghari M., “Radioisotopic<br />
cystography in diagnosis of vesicoureteral reflux.”, 16th International<br />
Congress of Pediatrics, Tehran, Iran, October 8-13, 2004.<br />
15. Eftekhari M., Arabi M., Beiki D., “ 90Y-Ibritumomab Tiuxetan in the treatment of<br />
relapsed or refractory B-cell non-Hodgkin's Lymphoma”, The 8th Annual<br />
Meeting of Nuclear Medicine, Tehran, Iran, 17-18 November, 2004.<br />
16. Fard A., Fallahi B., Olamaie R., Eftekhari M., Beiki D., Saghari M., “Quantitative<br />
assessment of salivary glands function in thyroid cancer patients after<br />
mhtml:file://C:\Documents and Settings\Dr\Desktop\<strong>CV</strong> Davood Beiki.mht<br />
Page 6 of 18<br />
<strong>2008</strong>/05/30
<strong>CV</strong>: Davood Beiki<br />
radioiodine therapy”, The 8th Annual Meeting of Nuclear Medicine, Tehran,<br />
Iran, 17-18 November, 2004.<br />
17. Eftekhari M., Akhavin-Ansari S., Sahimi-Izadian E., Beiki D., “Prevalence of<br />
depression in patients with differentiated thyroid cancer treated with radioactive<br />
iodine”, The 8th Annual Meeting of Nuclear Medicine, Tehran, Iran, 17-18<br />
November, 2004.<br />
18. Gheisari F., Eftekhari M., Beiki D., Hodjabr M., Fard A., Takavar A., Saghari M.,<br />
“Comparative study of renal function with 99mTc-MAG and 3 99mTc-EC”, The 8th Annual Meeting of Nuclear Medicine, Tehran, Iran, 17-18 November,<br />
2004.<br />
19. Fallahi B., Beiki D., “Health and safety aspects of nuclear medicine”, The 8th Annual Meeting of Nuclear Medicine, Tehran, Iran, 17-18 November,<br />
2004.<br />
20. Takavar A., Eftekhari M., Beiki D., “Internal dosimetry in nuclear medicine using<br />
a thyroid mathematical model”, The 8th Annual Meeting of Nuclear<br />
Medicine, Tehran, Iran, 17-18 November, 2004.<br />
21. Eftekhari M., Saghari M., Zakani A., Fard A., Akhzari F., Esmaeili J., Beiki D.,<br />
Fallahi B., “The effectiveness of 131I therapy in thyrogloboline positive 131I<br />
whole body scan negative patients with differentiated thyroid carcinoma”, The<br />
8th Annual Meeting of Nuclear Medicine, Tehran, Iran, 17-18 November,<br />
2004.<br />
22. Saghari M., Eftekhari M., Noorani H., Fard A., Beiki D., “Evaluation of diagnostic<br />
of 99mTc-Tetrofosmin scintigraphy in cold thyroid nodules”, The 8th Annual<br />
Meeting of Nuclear Medicine, Tehran, Iran, 17-18 November, 2004.<br />
23. Fard A., Emami F., Eftekhari M., Saghari M., Fallahi B., Beiki D., Takavar A.,<br />
“The value of myocardial perfusion imaging in differentiating between idiopathic<br />
dilated cardiomyopathy from the ischemic form”, The 8th Annual Meeting of<br />
Nuclear Medicine, Tehran, Iran, 17-18 November, 2004.<br />
24. Beiki D., Eftekhari M., Fallahi B., Fard A., “Production of positron emitter<br />
radiopharmaceuticals: radiolabelling techniques”, The 8th Annual Meeting of<br />
Nuclear Medicine, Tehran, Iran, 17-18 November, 2004.<br />
25. Fallahi B., Beiki D., Mahmoudian B., Gholamrezanezhad A., Fard A., “Can rest<br />
phase study be replaced by acquisition during low-dose dobutamine infusion in<br />
ECG-gated myocardial perfusion SPECT? A novel protocol.”, Annual Congress<br />
of the European Association of Nuclear Medicine, Istanbul, Turkey, 15-<br />
19 October, 2005.<br />
26. Eftekhari M., Saghari M., Assadi A., Kazemi M., Borghei H., Fard A., Fallahi B.,<br />
Beiki D., Mehdizadeh J., Naraghi M., “Posttraumatic anosmia: quantitative<br />
brain perfusion SPECT and clinical evaluation”, Annual Congress of the<br />
European Association of Nuclear Medicine, Istanbul, Turkey, 15-19<br />
October, 2005.<br />
27. Eftekhari M., Asadollahi A., Fallahi B., Izadyar S., Fard A., Beiki D., Saghari M.,<br />
“Bone mineral density in patients with differentiated thyroid cancer receiving<br />
suppressive dose of levothyroxine”, 52nd Annual Meeting of the Society of<br />
Nuclear Medicine, Toronto, Canada, 18-22 June, 2005.<br />
28. Eftekhari M, Gholamrezanezhad A, Beiki D, Fard A, Fallahi B, Mirpour S, Assadi<br />
M , Akbarpour S “ PET and pediatric neurological disorders”, 17th<br />
International Congress of Pediatrics, Imam Khomeini Hospital, Tehran,<br />
Iran, 2005.<br />
29. Fard Esfahani A, Mirpour S, Saghari M, Eftekhari M, Beiki D, Fallahi B,<br />
Gholamrezanezhad A, Assai M, Akbarpour S “Renal dynamic scan in the<br />
pediatric urinary infections”, 17th International Congress of Pediatrics,<br />
Imam Khomeini Hospital, Tehran, Iran, 2005.<br />
30. Saghari M, Assadi M, Eftekhari M, Fard-esfahani A, Beiki D, Mirpour S,<br />
Mahmoudian B,Gholamrezanezhad A, Akbarpour S, Nazarahari A “Current<br />
concepts on the diagnostic and therapeutic use of MIBG in children”, 17th<br />
International Congress of Pediatrics, Imam Khomeini Hospital, Tehran,<br />
Iran, 2005.<br />
31. Beiki D, Fard A, Eftekhari M, Fallahi B “Sedation Protocols In Pediatric Nuclear<br />
Medicine”, 17th International Congress of Pediatrics, Imam Khomeini<br />
mhtml:file://C:\Documents and Settings\Dr\Desktop\<strong>CV</strong> Davood Beiki.mht<br />
Page 7 of 18<br />
<strong>2008</strong>/05/30
<strong>CV</strong>: Davood Beiki<br />
Hospital, Tehran, Iran, 2005.<br />
32. Mahmoudian B, Fallahi B, Fard A, Beiki D “The role of thyroid scan in evaluating<br />
of congenital hypothyroidism”, 17th International Congress of Pediatrics,<br />
Imam Khomeini Hospital, Tehran, Iran, 2005.<br />
33. Fallahi B, Mahmoudian B, Beiki D, Fard A “Evaluation of congenital renal fusion<br />
anomalies with 99mTc-DMSA”, 17th International Congress of Pediatrics,<br />
Imam Khomeini Hospital, Tehran, Iran, 2005.<br />
34. Fard A, Eftekhari M, Emami F, Saghari M, Fallahi B, Beiki D, Takavar A “The<br />
value of myocardial perfusion imaging in differentiating between idiopathic<br />
dilated cardiomyopathy from the ischemic form”, Annual Congress of the<br />
European Association of Nuclear Medicine, Istanbul, Turkey, 2005.<br />
35. Fallahi B, Saghari M, Fard A, Dabbagh V, Eftekhari M, Beiki D, Iravani M “The<br />
value of Tc-99m-MIBI scintigraphy in multiple myeloma for early detection of<br />
relapsed disease and decesion for treatment”, Annual Congress of the<br />
European Association of Nuclear Medicine, Istanbul, Turkey, 2005.<br />
36. Fard A, Saghari M, Eftekhari M, Sadeghi R, Fallahi B, Beiki D, Takavar A “Bone<br />
SPECT value for differentiating malignant from benign lesions of vertebral<br />
column in patients with known primary malignancy”, Annual Congress of the<br />
European Association of Nuclear Medicine, Istanbul, Turkey, 2005.<br />
37. Esfahani A.F., Fallahi B., Kakhki V.R.D., Eftekhari M., Beiki D., Saghari M.<br />
“Comparative evaluation of the two fixed dose methods of radioiodine therapy<br />
(185 MBq and 370 MBq) for the treatment of graves' disease”, International<br />
Conference on Radiopharmaceutical Therapy (ICRT-2005), Limassol,<br />
Cyprus, 11-14 October 2005.<br />
38. Eftekhari M., Fallahi B., Ansari S., Izadian E.S., Esfahani A.F., Beiki D., Saghari<br />
M. “The rate of depression and its risk stratification in patients with<br />
differentiated thyroid cancers treated with radioactive iodine”, International<br />
Conference on Radiopharmaceutical Therapy (ICRT-2005), Limassol,<br />
Cyprus, 11-14 October 2005.<br />
39. Takavar A., Eftekhari M., Fard-Esfahani A., Beiki D., “Study of ablation<br />
efficiency of 3600 MBq of I-131 in the treatment of thyroid carcinoma”,<br />
International Conference on Radiopharmaceutical Therapy (ICRT-<br />
2005), Limassol, Cyprus, 11-14 October 2005.<br />
40. Gholamrezanezhad A., Saghari M., Mirpour S., Beiki D., Fallahi B. “Efficacy of<br />
high dose radioiodine in the treatment of elevated serum thyroglobulin in<br />
patients with differentiated thyroid carcinoma and negative whole body iodine<br />
scan” 8th European Congress of Endocrinology Glasgow, UK 2006.<br />
41. Beiki D.,Dowlatabadi R., Khalaj A., Eftekhari M., Fard A., Fallahi B. “Application<br />
of Microdose Radiolabeled 14C-Urea for the Detection of Helicobacter Pylori<br />
Infection”, The 8th National Congress of Microbiology, Isfahan, Iran, 23-<br />
25 <strong>May</strong> 2006.<br />
42. Gholamrezanezhad A., Saghari M., Mirpour S., Beiki D., “On-levothyroxine<br />
measurement of thyroglobulin is not a reliable screening test for patients at high<br />
risk of remnant/recurrent differentiated thyroid carcinoma”, 8th European<br />
Congress of Endocrinology, Glasgow, UK 2006.<br />
43. Saghari M., Mirpour S., Gholamrezanezhad A., Beiki D., “Review of the role of<br />
nuclear medicine in the management of the adrenal diseases”, 13th Asia-<br />
Oceania Congress of Endocrinology, Tehran, Iran, 10-12 <strong>May</strong> 2006.<br />
44. Beiki D., Dowlatabadi R., Khalaj A., Eftekhari M., Fard A., Fallahi B., “Application<br />
of microdose radiolabeled 14C-Urea for the detection of Helicobacter Pylori<br />
infection”, 8th National Congress of Microbiology, Isfahan, Iran, 23-25<br />
<strong>May</strong> 2006.<br />
45. Ansari-Gilani K., Fallahi B., Modaresi-Esfeh J., Beiki D., Fard-Esfahani A., “Is<br />
there any correlation between the severity of anxiety and myocardial perfusion<br />
abnormalities detected by SPECT imaging? ”, 19th Annual Congress of the<br />
European Association of Nuclear Medicine, Athens, Greece, Sep 30-4 Oct<br />
2006.<br />
46. Eftekhari M., Assadi M., Hozhabrosadati M., Saghari M., Fard-Esfahani A., Fallahi<br />
Sichani B., Beiki D., “Comparison of methods for determination of glomerular<br />
filtration rate: low and high dose Tc-99m-DTPA renography, predicted creatinine<br />
mhtml:file://C:\Documents and Settings\Dr\Desktop\<strong>CV</strong> Davood Beiki.mht<br />
Page 8 of 18<br />
<strong>2008</strong>/05/30
<strong>CV</strong>: Davood Beiki<br />
clearance method and plasma sample method”, 19th Annual Congress of the<br />
European Association of Nuclear Medicine, Athens, Greece, Sep 30-4 Oct<br />
2006.<br />
47. Eftekhari M., Arabi M., Memari F., Arab kheradmand A., Esmaili J.,<br />
Gholamrezanezhad A., Beiki D., Fard-Esfahani A., Fallahi sichani B., “Assessing<br />
the diagnostic accuracy of sentinel lymph nodes lymphoscintigraphy using<br />
99m th Tc-phytate in breast cancer”, 19 Annual Congress of the European<br />
Association of Nuclear Medicine, Athens, Greece, Sep 30-4 Oct 2006.<br />
48. Fallahi sichani B., Saghari M., Arab-Kheradmand A. , Eftekhari M., Ghadimi K.,<br />
Beiki D., , Fard-Esfahani A., “ 99mTc-Phytate vs. 99mTc-Sb S for lymphatic<br />
2 3<br />
mapping and gamma-guided sentinel lymph node biopsy in breast cancer: a<br />
comparative study ”, 19th Annual Congress of the European Association<br />
of Nuclear Medicine, Athens, Greece, Sep 30-4 Oct 2006.<br />
49. Fard-Esfahani A., Fallahi B., Khatami K., Eftekhari M., Saghari M., Beiki D., A.<br />
Takavar, “Correlation of two methods of planar and SPECT scintigraphy with Tc-<br />
99m RBC in detection of liver hemangioma”, 19th Annual Congress of the<br />
European Association of Nuclear Medicine, Athens, Greece, Sep 30-4 Oct<br />
2006.<br />
50. Fard-Esfahani A., Mirshekarpour H., Fallahi B., Eftekhari M., Saghari M., Beiki<br />
D., Takavar A., “Radioiodine treatment effects on lacrimal gland function in<br />
patients with thyroid cancer”, 19th Annual Congress of the European<br />
Association of Nuclear Medicine, Athens, Greece, Sep 30-4 Oct 2006.<br />
51. Beiki D., Eftekhari M., Fallahi B., Gheisari F., Hojabrossadat M., Fard-Esfahani<br />
A., Ansari-Gilani K.., “ 99mTc-EC vs. 99mTc-MAG : A comparative study of two<br />
3<br />
radiopharmaceuticals for renal function assessment ”, 19th Annual Congress<br />
of the European Association of Nuclear Medicine, Athens, Greece, Sep<br />
30-4 Oct 2006.<br />
52. Saghari M., Ansari-Gilani K., Fallahi B., Beiki D., Fard-Esfahani A., Eftekhari M.,<br />
“Pre-treatment preparation of patients with differentiated thyroid carcinoma<br />
within three weeks ”, 19th Annual Congress of the European Association of<br />
Nuclear Medicine, Athens, Greece, Sep 30-4 Oct 2006.<br />
53. Beiki D., Fallahi B., Akbarpour S., Akhzari F., Izadyar S., Esmaeili J., Saghari<br />
M., Eftekhari M., Fard-Esfahani A., “Discontinuing of long-term beta-blocker<br />
therapy may falsely overestimate the fixed defects in dipyridamole myocardial<br />
perfusion imaging ”, 19th Annual Congress of the European Association of<br />
Nuclear Medicine, Athens, Greece, Sep 30-4 Oct 2006.<br />
54. Fard A., Assadi M., Mohagheghi A., Saghari M., Eftekhari M., Fallahi B., Beiki D.,<br />
Ansari K., Takavar A., Izadyar S., Akhzari F., "Myocardial perfusion scintigraphy<br />
role in evaluating percutaneous transluminal coronary angioplasty (PTCA) in<br />
patients with coronary artery disease", 9th Congress of World Federation of<br />
Nuclear Medicine & Biology, Seoul, Korea, 22-27 Oct. 2006.<br />
55. Saghari M., Assadi M., Eftekhari M., Yaghoobi M., Gholamrezanezhad A., Fallahi<br />
B., Fard A., Beiki D., Ansari K., Esmaeili J., Takavar A., "Angiographic and<br />
scintigraphic features of cardiac X syndrome", 9th Congress of World<br />
Federation of Nuclear Medicine & Biology, Seoul, Korea, 22-27 Oct.<br />
2006.<br />
56. Gholamrezanezhad A., Mirpour S., Saghari M., Eftekhari M., Beiki D., Fallahi B.,<br />
Fard A., "Efficacy of radioiodine therapy in the treatment of elevated serum<br />
thyroglobuline in patients with differentiated thyroid carcinoma and negative<br />
whole body iodine scan ", 9th Congress of World Federation of Nuclear<br />
Medicine & Biology, Seoul, Korea, 22-27 Oct. 2006.<br />
57. Assadi M., Gholamrezanezhad A., Saghari M., Eftekhari M., Fallahi B., Fard A.,<br />
Beiki D., Akbarpour S., Gholamrezanezhad A., Takavar A., "Comparison<br />
between brain perfusion single photon emission computed tomography and<br />
anatomical imaging in chronic complications of traumatic head injury",9th Congress of World Federation of Nuclear Medicine & Biology, Seoul,<br />
Korea, 22-27 Oct. 2006.<br />
58. Eftekhari M., Assadi M., Kazemi M., Saghari M., Fard A., Fallahi B.,<br />
Gholamrezanezhad A., Beiki D., Takavar A., "Neurospect evaluation in patients<br />
with post traumatic anosmia; a preliminary study", 9th Congress of World<br />
mhtml:file://C:\Documents and Settings\Dr\Desktop\<strong>CV</strong> Davood Beiki.mht<br />
Page 9 of 18<br />
<strong>2008</strong>/05/30
<strong>CV</strong>: Davood Beiki<br />
Federation of Nuclear Medicine & Biology, Seoul, Korea, 22-27 Oct. 2006.<br />
59. Fard A., Gholamrezanezhad A., Eftekhari M., Saghari M., Fallahi B., Beiki D.,<br />
Takavar A., Mirpour S., "Assessment of the Accuracy of lacrimal scintigraphy<br />
based on a prospective analysis of patients symptomatology", 9th Congress of<br />
World Federation of Nuclear Medicine & Biology, Seoul, Korea, 22-27<br />
Oct. 2006.<br />
60. Beiki D., Dowlatabadi R., " Radiopharmaceutical regulation world wide- the<br />
resemblances and differences", 9th Congress of World Federation of<br />
Nuclear Medicine & Biology, Seoul, Korea, 22-27 Oct. 2006.<br />
61. Mirpour S., Fard A., Gholamrezanezhad A., Eftekhari M., Saghari M., Fallahi B.,<br />
Beiki D., Takavar A., "Quantitative assessment of dacrioscintigraphic images in<br />
the evaluation of epiphora", 9th Congress of World Federation of Nuclear<br />
Medicine & Biology, Seoul, Korea, 22-27 Oct. 2006.<br />
62. Fard A., Fallahi B., Beiki D., Eftekhari M., Saghari M., Takavar A., Ansari K.,"<br />
Myocardial perfusion scan accuracy in detection of coronary artery disease –<br />
comparison with exercise stress test", 9th Congress of World Federation of<br />
Nuclear Medicine & Biology, Seoul, Korea, 22-27 Oct. 2006.<br />
63. Fallahi B., Saghari M., Beiki D., Fard A., Eftekhari M., Gholamrezanezhad A.,<br />
"Comparison between three interpretative methods for diagnosis of coronary<br />
artery disease in the territory of left anterior descending artery by dipyridamole<br />
myocardial perfusion imaging in patients with left bundle branch block", 9th Congress of World Federation of Nuclear Medicine & Biology, Seoul,<br />
Korea, 22-27 Oct. 2006.<br />
64. Fallahi B., Beiki D., Akbarpour S., Akhzari F., Izadyar S., Esmaeili J., Eftekhari<br />
M., Fard A., Saghari M., " Discontinuing of long-term beta-blocker therapy may<br />
falsely overestimate the fixed defects in dipyridamole myocardial perfusion<br />
imaging",9th Congress of World Federation of Nuclear Medicine &<br />
Biology, Seoul, Korea, 22-27 Oct. 2006.<br />
65. Beiki D., Dowlatabadi R., Fallahi B., Eftekhari M., Khalaj A., Fard A., Ansari K.,<br />
"Microdose C-14 urea breath test for the diagnosis of helicobacter pylori", 9th Congress of World Federation of Nuclear Medicine & Biology, Seoul,<br />
Korea, 22-27 Oct. 2006.<br />
66. Beiki D., Dowlatabadi R., Fallahi B., Eftekhari M., Fard A., Khalaj A., Ansari K.,<br />
"C-13 UBT by non dispersive isotope selected infrared (NDIR) spectroscopy vs<br />
C-14 UBT in diagnosis of HP infection", 9th Congress of World Federation of<br />
Nuclear Medicine & Biology, Seoul, Korea, 22-27 Oct. 2006.<br />
67. Ansari K., Fallahi B., Eftekhari M., Fard A., Beiki D., "Changes in gonadal function<br />
in hyperthyroid patients treated with radioiodine", 9th Congress of World<br />
Federation of Nuclear Medicine & Biology, Seoul, Korea, 22-27 Oct.<br />
2006.<br />
68. Eftekhari M., Noorani M., Beiki D., Saghari M., Fallahi B., Fard A., "Diagnostic<br />
role of Tc-99m Tetrofosmin scintigraphy in cold thyroid nodules", 9th Congress<br />
of World Federation of Nuclear Medicine & Biology, Seoul, Korea, 22-27<br />
Oct. 2006.<br />
69. Eftekhari M., Arabi M., Esmaeili J., Akhzari F., Fallahi B., Beiki D., Saghari M.,<br />
Fard A. Gholamrezanezhad A., "Assessing the diagnostic accuracy of sentinel<br />
lymph nodes lymphoscintigraphy using Tc-99m Phytate in breast cancer", 9th Congress of World Federation of Nuclear Medicine & Biology, Seoul,<br />
Korea, 22-27 Oct. 2006.<br />
70. Fard-Esfahani A., Mohagheghi A., Assadi M., Fallahi B., Saghari M., Akhzari F.,<br />
Izadyar S., Eftekhari M., Beiki D., Takavar A., Ansari-Gilani K., " The role of<br />
scintigraphic perfusion imaging in the evaluation of patients before and after<br />
percutaneous transluminal coronary angioplasty (PTCA)", 10th Iranian Annual<br />
Congress of Nuclear Medicine, Tehran, Iran, 6-7 December 2006.<br />
71. Saghari M., Vakili A., Gholamrezanezhad A., Mirpour S., Beiki D., Sadjadi A.,<br />
Farahani M.H., " The long term effects of mustard gas on myocardial perfusion<br />
pattern of intoxicated warfare patients", 10th Iranian Annual Congress of<br />
Nuclear Medicine, Tehran, Iran, 6-7 December 2006.<br />
72. Saghari M., Eftekhari M., Assadi M., Pourbehi M.R., Fard-Esfahani A., Nasiri M.,<br />
Fallahi B., Beiki D.,Takavar A., Nazarahari M., " The relation between<br />
mhtml:file://C:\Documents and Settings\Dr\Desktop\<strong>CV</strong> Davood Beiki.mht<br />
Page 10 of 18<br />
<strong>2008</strong>/05/30
<strong>CV</strong>: Davood Beiki<br />
helicobacter pylori infection and cardiac syndrome X; a preliminary study", 10th Iranian Annual Congress of Nuclear Medicine, Tehran, Iran, 6-7<br />
December 2006.<br />
73. Fallahi B., Beiki D., Mahmoudian B., Gholamrezanezhad A., Fard-Esfahani A.,<br />
Eftekhari M., Hozhabrossadati M., " Evaluation of a new mono-phasic imaging<br />
protocol in comparison with conventional dual-phase study of myocardial<br />
perfusion", 10th Iranian Annual Congress of Nuclear Medicine, Tehran,<br />
Iran, 6-7 December 2006.<br />
74. Fallahi B., Saghari M., Eftekhari M., Fard-Esfahani A., Beiki D., Yamini-Sharif<br />
A., Kamalhedayat D., Gholamrezanezhad A., Sadeghi Sh., Ansari M., Ansari-<br />
Gilani K., " The best pattern of interpretation in dipyridamole myocardial<br />
perfusion scan for diagnosis of coronary artery disease in the territory of left<br />
anterior descending artery in patients with left bundle branch block", 10th Iranian Annual Congress of Nuclear Medicine, Tehran, Iran, 6-7<br />
December 2006.<br />
75. Beiki D., Fallahi B., Akbarpour S., Akhzari F., Izadyar S., Esmaeili J., Saghari<br />
M., Eftekhari M., Fard-Esfahani A., “Discontinuing of long-term beta-blocker<br />
therapy may falsely overestimate the fixed defects in dipyridamole myocardial<br />
perfusion imaging”, 10th Iranian Annual Congress of Nuclear Medicine,<br />
Tehran, Iran, 6-7 December 2006.<br />
76. Fard-Esfahani A., Fallahi B., Saghari M., Eftekhari M., Beiki D., Takavar A.,<br />
Ansari-Gilani K., “Accuracy of myocardial perfusion scan in detection of coronary<br />
artery disease- comparison with exercise stress test”, 10th Iranian Annual<br />
Congress of Nuclear Medicine, Tehran, Iran, 6-7 December 2006.<br />
77. Beiki D., Fallahi B., “Nuclear medicine imaging techniques in the evaluation of<br />
pharmaceutical formulations”, 10th Iranian Annual Congress of Nuclear<br />
Medicine, Tehran, Iran, 6-7 December 2006.<br />
78. Saghari M., Gholamrezanezhad A., Mirpour S., Fallahi B., Beiki D., Sadjadi A.,<br />
Addollahzadeh J., “On-levothyroxine measurement of thyroglobulin is not a<br />
reliable screening test for patients at high risk of remnant/recurrent<br />
differentiated thyroid carcinoma”, 10th Iranian Annual Congress of Nuclear<br />
Medicine, Tehran, Iran, 6-7 December 2006.<br />
79. Gholamrezanezhad A., Fard A., Sadeghi Tari A., Mirpour S., Fallahi B., Beiki D.,<br />
“Analysis of dacryoscintigraphic images based on a simple quantitative<br />
measure”, 10th Iranian Annual Congress of Nuclear Medicine, Tehran,<br />
Iran, 6-7 December 2006.<br />
80. Fard A., Saghari M., Gholamrezanezhad A., Mirpour S., Sadjadi A., Fallahi B.,<br />
Beiki D., “Assessment of the accuracy of lacrimal scintigraphy based on a<br />
prospective analysis of patients’ symptomatology”, 10th Iranian Annual<br />
Congress of Nuclear Medicine, Tehran, Iran, 6-7 December 2006.<br />
81. Eftekhari M., Assadi M., Kazemi M., Saghari M., Fard-Esfahani A., Fallahi B.,<br />
Takavar A., Gholamrezanezhad A., Beiki D., “NeuroSPECT evaluation in<br />
patients with post-traumatic anosmia, a preliminary study”, 10th Iranian<br />
Annual Congress of Nuclear Medicine, Tehran, Iran, 6-7 December<br />
2006.<br />
82. Eftekhari M., Saghari M., Assadi M., Fallahi B., Fard-Esfahani A., Takavar A.,<br />
Beiki D., Akbarpour S., Gholamrezanezhad A., Nazarahari M., “Comparison<br />
between brain perfusion single photon emission computed tomography (SPECT)<br />
and anatomical imaging in chronic complications of traumatic head injury”, 10th Iranian Annual Congress of Nuclear Medicine, Tehran, Iran, 6-7<br />
December 2006.<br />
83. Fard-Esfahani A., Saghari M., Eftekhari M., Beiki D., Fallahi B., Takavar A.,<br />
Ansari-Gilani K., "Nuclear medicine role in neonatal jaundice", 18th International Congress of Pediatrics, Tehran, Iran, 27 Oct-1 Nov 2006.<br />
84. Beiki D., Fard-Esfahani A., Fallahi B., Eftekhari M., Ansari-Gilani K., "Indirect<br />
radionuclide cystography in children", 18th International Congress of<br />
Pediatrics, Tehran, Iran, 27 Oct-1 Nov 2006.<br />
85. Ansari-Gilani K., Beiki D., Fard-Esfahani A., Fallahi B., Eftekhari M., "Renal<br />
cortical scintigraphy in children", 18th International Congress of Pediatrics,<br />
Tehran, Iran, 27 Oct-1 Nov 2006.<br />
mhtml:file://C:\Documents and Settings\Dr\Desktop\<strong>CV</strong> Davood Beiki.mht<br />
Page 11 of 18<br />
<strong>2008</strong>/05/30
<strong>CV</strong>: Davood Beiki<br />
86. Fard-Esfahani A., Mirshekarpour H., Fallahi B., Eftekhari M., Takavar A., Beiki<br />
D., Ansari-Gilani K., Saghari M., "Radioiodine therapy effects on lacrimal gland<br />
function in patients with thyroid cancer", 2nd Conference of Asia Regional<br />
Cooperative Council of Nuclear Medicine (ARCCNM), Ulaanbaatar,<br />
Mongolia, 3-7 September 2007.<br />
87. Eftekhari M., Assadollahi A., Assadi M., Izadyar S., Fard-Esfahani A., Fallahi B.,<br />
Beiki D., Takavar A., Ansari-Gilani K., "Mineral Density in patients with welldifferentiated<br />
thyroid carcinoma", 2nd Conference of Asia Regional<br />
Cooperative Council of Nuclear Medicine (ARCCNM), Ulaanbaatar,<br />
Mongolia, 3-7 September 2007.<br />
88. Takavar A., Saghari M., Gholamrezanezhad A., Mirpour S., Fallahi B., Fard-<br />
Esfahani Beiki D., Eftekhari M., Sassan S., "Efficacy of Radioiodine therapy in<br />
patients of differentiated thyroid cancer with elevated serum thyroglobulin and<br />
negative I-131 scan ", 2nd Conference of Asia Regional Cooperative<br />
Council of Nuclear Medicine (ARCCNM), Ulaanbaatar, Mongolia, 3-7<br />
September 2007.<br />
89. Fard-Esfahani A., Fallahi B., Hadifar M., Beiki D., Eftekhari M., Saghari M.,<br />
Takavar A., "Radioiodine treatment complications in mother and child in patients<br />
with differentiated thyroid carcinoma", Joint Annual Scientific Meeting,<br />
CARO-COMP, Toronto, Canada, 9-13 October 2007.<br />
90. Eftekhari M., M Asadi, Fard-Esfahani A., Beiki D., Fallahi B., M. Yaghoubi, M.,<br />
Saghari M., "Angiographic findings in cardiac syndrome X (CSX) comparing with<br />
myocardial perfusion imaging (MPI) and exercise treadmill test (ETT) ", 20th Annual Congress of the European Association of Nuclear Medicine,<br />
Copenhagen, Denmark, October 13-17, 2007.<br />
91. Fallahi B., Beiki D., Mousavi A., Gholamrezanezhad A., Ansari Gilani K., Fard-<br />
Esfahani A., S. Mirpour, K. Alimoghaddam, Eftekhari M., "The value of 99mTc- MIBI scintigraphy for the diagnosis of multiple drug resistance in multiple<br />
myeloma patients", 20th Annual Congress of the European Association of<br />
Nuclear Medicine, Copenhagen, Denmark, October 13-17, 2007.<br />
92. Eftekhari M., Asadi M., Fard-Esfahani A., Akbarpor S., Gholamrezanezhad A.,<br />
Fallahi B., Beiki D., Saghari M. "Brain perfusion abnormalities in patients with<br />
chronic symptoms studied with Technetium-99m ethyl cysteinate dimmer<br />
( 99mTc-ECD) more than one year", 20th Annual Congress of the European<br />
Association of Nuclear Medicine, Copenhagen, Denmark, October 13-17,<br />
2007.<br />
93. Beiki D., Fallahi B., Khalaj A., Rafiee H., Najafi R. "Simple synthesis of<br />
radioiodinated N-succinimidyl-4iodobenzoate: an intermediate compound for the<br />
indirect radioiodination of antibodies", 20th Annual Congress of the<br />
European Association of Nuclear Medicine, Copenhagen, Denmark,<br />
October 13-17, 2007.<br />
94. Beiki D., Fallahi B., Dadashzadeh S., Shahhosseini S., Eftekhari M., Fard-<br />
Esfahani A. "Hospital discharge policy in patients receiving iodine-131 therapy<br />
for thyroid carcinoma based on monitoring of radiation dose rate and<br />
radioiodine urinary excretion", 20th Annual Congress of the European<br />
Association of Nuclear Medicine, Copenhagen, Denmark, October 13-17,<br />
2007.<br />
95. Zakani A., Saghari M., Eftekhari M., Fard-Esfahani A. Asadi M., Fallahi B., Beiki<br />
D., "Evaluation of radioiodine therapy in differentiated thyroid cancer (DTC) in<br />
patients with negative diagnostic I-131 whole body scans and elevated serum<br />
thyroglobulin levels: a comparison study with thallium scan", 20th Annual<br />
Congress of the European Association of Nuclear Medicine, Copenhagen,<br />
Denmark, October 13-17, 2007.<br />
C. Abstracts in Journals<br />
1. Shahhosseini S., Beiki D., Khalaj A., Eftekhari M. “Reduction of in vivo<br />
deiodination of radioiodinated of antibodies using N-succinimidyl-4-[ 125I] iodobenzoate”, Revista Medicina Nuclear Alasbimn Journal, 2002; Year 5,<br />
N 17 (abstract no. 413). [English]<br />
2. Eftekhari M., Takavar A., Ansari K., Fard A., Beiki D. “Effects of treatment with<br />
radioiodine (I-131) on the gonadal function of the hyperthyroid patients.”,<br />
mhtml:file://C:\Documents and Settings\Dr\Desktop\<strong>CV</strong> Davood Beiki.mht<br />
Page 12 of 18<br />
<strong>2008</strong>/05/30
<strong>CV</strong>: Davood Beiki<br />
Journal of Nuclear Medicine, 2004; 45(5): 19P-20P(abstract no. 54).<br />
[English]<br />
3. Fard A., Eftekhari M., Fallahi B., Beiki D., Saghari M., “Radioisotopic<br />
cystography in diagnosis of vesicoureteral reflux.”, Iranian Journal of<br />
Pediatrics, 2004; 13(Suppl 2): 101. [English]<br />
4. Fallahi B., Beiki D., Mahmoudian B., Gholamrezanezhad A., Fard A., “Can rest<br />
phase study be replaced by acquisition during low-dose dobutamine infusion in<br />
ECG-gated myocardial perfusion SPECT? A novel protocol.”, European Journal<br />
of Nuclear Medicine and Molecular Imaging, 2005; 32(Suppl 1): S12,<br />
(abstract no. 16). [English]<br />
5. Eftekhari M., Saghari M., Assadi A., Kazemi M., Borghei H., Fard A., Fallahi B.,<br />
Beiki D., Mehdizadeh J., Naraghi M., “Posttraumatic anosmia: quantitative<br />
brain perfusion SPECT and clinical evaluation”, European Journal of Nuclear<br />
Medicine and Molecular Imaging, 2005; 32(Suppl 1): S183, (abstract<br />
no. P306). [English]<br />
6. Eftekhari M., Asadollahi A., Fallahi B., Izadyar S., Fard A., Beiki D., Saghari M.,<br />
“Bone mineral density in patients with differentiated thyroid cancer receiving<br />
suppressive dose of levothyroxine”, Journal of Nuclear Medicine, 2005; 46<br />
(2): 311P(abstract no. 1017). [English]<br />
7. Eftekhari M, Gholamrezanezhad A, Beiki D, Fard A, Fallahi B, Mirpour S, Assadi<br />
M , Akbarpour S “ PET and pediatric neurological disorders”, Iranian Journal<br />
of Pediatrics, 2005; 15(Suppl 1): 53. [English]<br />
8. Fard Esfahani A, Mirpour S, Saghari M, Eftekhari M, Beiki D, Fallahi B,<br />
Gholamrezanezhad A, Assai M, Akbarpour S “Renal dynamic scan in the<br />
pediatric urinary infections”, Iranian Journal of Pediatrics, 2005; 15(Suppl<br />
1): 56. [English]<br />
9. Saghari M, Assadi M, Eftekhari M, Fard-esfahani A, Beiki D, Mirpour S,<br />
Mahmoudian B,Gholamrezanezhad A, Akbarpour S, Nazarahari A “Current<br />
concepts on the diagnostic and therapeutic use of MIBG in children”, Iranian<br />
Journal of Pediatrics, 2005; 15(Suppl 1): 52. [English]<br />
10. Beiki D, Fard A, Eftekhari M, Fallahi B “Sedation Protocols In Pediatric Nuclear<br />
Medicine”, Iranian Journal of Pediatrics, 2005; 15(Suppl 1): 54. [English]<br />
11. Mahmoudian B, Fallahi B, Fard A, Beiki D “The role of thyroid scan in evaluating<br />
of congenital hypothyroidism”, Iranian Journal of Pediatrics, 2005; 15<br />
(Suppl 1): 55. [English]<br />
12. Fallahi B, Mahmoudian B, Beiki D, Fard A “Evaluation of congenital renal fusion<br />
anomalies with 99mTc-DMSA”, Iranian Journal of Pediatrics, 2005; 15<br />
(Suppl 1): 55. [English]<br />
13. Fard A, Eftekhari M, Emami F, Saghari M, Fallahi B, Beiki D, Takavar A “The<br />
value of myocardial perfusion imaging in differentiating between idiopathic<br />
dilated cardiomyopathy from the ischemic form”, European Journal of<br />
Nuclear Medicine and Molecular Imaging, 2005; 32(Suppl 1): S178,<br />
(abstract no. P283). [English]<br />
14. Fallahi B, Saghari M, Fard A, Dabbagh V, Eftekhari M, Beiki D, Iravani M “The<br />
value of Tc-99m-MIBI scintigraphy in multiple myeloma for early detection of<br />
relapsed disease and decesion for treatment”, European Journal of Nuclear<br />
Medicine and Molecular Imaging, 2005; 32(Suppl 1): S99, (abstract no.<br />
373). [English]<br />
15. Fard A, Saghari M, Eftekhari M, Sadeghi R, Fallahi B, Beiki D, Takavar A “Bone<br />
SPECT value for differentiating malignant from benign lesions of vertebral<br />
column in patients with known primary malignancy”, European Journal of<br />
Nuclear Medicine and Molecular Imaging, 2005; 32(Suppl 1): S132,<br />
(abstract no. P45). [English]<br />
16. Esfahani A.F., Fallahi B., Kakhki V.R.D., Eftekhari M., Beiki D., Saghari M.<br />
“Comparative evaluation of the two fixed dose methods of radioiodine therapy<br />
(185 MBq and 370 MBq) for the treatment of graves' disease”, World Journal<br />
of Nuclear Medicine, 2005; 4(1): S37 (abstract no. 052-IRA) . [English]<br />
17. Eftekhari M., Fallahi B., Ansari S., Izadian E.S., Esfahani A.F., Beiki D., Saghari<br />
M. “The rate of depression and its risk stratification in patients with<br />
differentiated thyroid cancers treated with radioactive iodine”, World Journal<br />
mhtml:file://C:\Documents and Settings\Dr\Desktop\<strong>CV</strong> Davood Beiki.mht<br />
Page 13 of 18<br />
<strong>2008</strong>/05/30
<strong>CV</strong>: Davood Beiki<br />
of Nuclear Medicine, 2005; 4(1): S37 (abstract no. 053-IRA) . [English]<br />
18. Takavar A., Eftekhari M., Fard-Esfahani A., Beiki D., “Study of ablation<br />
efficiency of 3600 MBq of I-131 in the treatment of thyroid carcinoma”, World<br />
Journal of Nuclear Medicine, 2005; 4(1): S38 (abstract no. 055-IRA) .<br />
[English]<br />
19. Gholamrezanezhad A., Saghari M., Mirpour S., Beiki D., Fallahi B. “Efficacy of<br />
high dose radioiodine in the treatment of elevated serum thyroglobulin in<br />
patients with differentiated thyroid carcinoma and negative whole body iodine<br />
scan” Endocrine Abstracts, 2006; 11(P895). [English]<br />
20. Gholamrezanezhad A., Saghari M., Mirpour S., Beiki D., “On-levothyroxine<br />
measurement of thyroglobulin is not a reliable screening test for patients at high<br />
risk of remnant/recurrent differentiated thyroid carcinoma”, Endocrine<br />
Abstracts, 2006; 11(P835). [English]<br />
21. Ansari-Gilani K., Fallahi B., Modaresi-Esfeh J., Beiki D., Fard-Esfahani A., “Is<br />
there any correlation between the severity of anxiety and myocardial perfusion<br />
abnormalities detected by SPECT imaging? ”, European Journal of Nuclear<br />
Medicine and Molecular Imaging, 2005; 33(Suppl 2): S106, (abstract<br />
no. 110) . [English]<br />
22. Eftekhari M., Assadi M., Hozhabrosadati M., Saghari M., Fard-Esfahani A., Fallahi<br />
Sichani B., Beiki D., “Comparison of methods for determination of glomerular<br />
filtration rate: low and high dose Tc-99m-DTPA renography, predicted creatinine<br />
clearance method and plasma sample method”, European Journal of Nuclear<br />
Medicine and Molecular Imaging, 2005; 33(Suppl 2): S113, (abstract<br />
no. 143) . [English]<br />
23. Eftekhari M., Arabi M., Memari F., Arab kheradmand A., Esmaili J.,<br />
Gholamrezanezhad A., Beiki D., Fard-Esfahani A., Fallahi sichani B., “Assessing<br />
the diagnostic accuracy of sentinel lymph nodes lymphoscintigraphy using<br />
99mTc-phytate in breast cancer”, European Journal of Nuclear Medicine and<br />
Molecular Imaging, 2005; 33(Suppl 2): S132, (abstract no. 232) .<br />
[English]<br />
24. Fallahi sichani B., Saghari M., Arab-Kheradmand A. , Eftekhari M., Ghadimi K.,<br />
Beiki D., , Fard-Esfahani A., “ 99mTc-Phytate vs. 99mTc-Sb S for lymphatic<br />
2 3<br />
mapping and gamma-guided sentinel lymph node biopsy in breast cancer: a<br />
comparative study ”, European Journal of Nuclear Medicine and Molecular<br />
Imaging, 2005; 33(Suppl 2): S275, (abstract no. P240). [English]<br />
25. Fard-Esfahani A., Fallahi B., Khatami K., Eftekhari M., Saghari M., Beiki D., A.<br />
Takavar, “Correlation of two methods of planar and SPECT scintigraphy with Tc-<br />
99m RBC in detection of liver hemangioma”, European Journal of Nuclear<br />
Medicine and Molecular Imaging, 2005; 33(Suppl 2): S282, (abstract<br />
no. P275). [English]<br />
26. Fard-Esfahani A., Mirshekarpour H., Fallahi B., Eftekhari M., Saghari M., Beiki<br />
D., Takavar A., “Radioiodine treatment effects on lacrimal gland function in<br />
patients with thyroid cancer”, European Journal of Nuclear Medicine and<br />
Molecular Imaging, 2005; 33(Suppl 2): S329, (abstract no. P513).<br />
[English]<br />
27. Beiki D., Eftekhari M., Fallahi B., Gheisari F., Hojabrossadat M., Fard-Esfahani<br />
A., Ansari-Gilani K.., “ 99mTc-EC vs. 99mTc-MAG : A comparative study of two<br />
3<br />
radiopharmaceuticals for renal function assessment ”, European Journal of<br />
Nuclear Medicine and Molecular Imaging, 2005; 33(Suppl 2): S348,<br />
(abstract no. P610) . [English]<br />
28. Saghari M., Ansari-Gilani K., Fallahi B., Beiki D., Fard-Esfahani A., Eftekhari M.,<br />
“Pre-treatment preparation of patients with differentiated thyroid carcinoma<br />
within three weeks ”, European Journal of Nuclear Medicine and Molecular<br />
Imaging, 2005; 33(Suppl 2): S353, (abstract no. P637). [English]<br />
29. Beiki D., Fallahi B., Akbarpour S., Akhzari F., Izadyar S., Esmaeili J., Saghari<br />
M., Eftekhari M., Fard-Esfahani A., “Discontinuing of long-term beta-blocker<br />
therapy may falsely overestimate the fixed defects in dipyridamole myocardial<br />
perfusion imaging ”, European Journal of Nuclear Medicine and Molecular<br />
Imaging, 2005; 33(Suppl 2): S387, (abstract no. TP39). [English]<br />
30. Fard A., Assadi M., Mohagheghi A., Saghari M., Eftekhari M., Fallahi B., Beiki D.,<br />
mhtml:file://C:\Documents and Settings\Dr\Desktop\<strong>CV</strong> Davood Beiki.mht<br />
Page 14 of 18<br />
<strong>2008</strong>/05/30
<strong>CV</strong>: Davood Beiki<br />
Ansari K., Takavar A., Izadyar S., Akhzari F., "Myocardial perfusion scintigraphy role<br />
in evaluating percutaneous transluminal coronary angioplasty (PTCA) in patients<br />
with coronary artery disease", World Journal of Nuclear Medicine, 2006; 5<br />
(Suppl 1): S36, (abstract no. 2038). [English]<br />
31. Saghari M., Assadi M., Eftekhari M., Yaghoobi M., Gholamrezanezhad A., Fallahi<br />
B., Fard A., Beiki D., Ansari K., Esmaeili J., Takavar A., "Angiographic and<br />
scintigraphic features of cardiac X syndrome", World Journal of Nuclear<br />
Medicine, 2006; 5(Suppl 1): S36, (abstract no. 2039). [English]<br />
32. Gholamrezanezhad A., Mirpour S., Saghari M., Eftekhari M., Beiki D., Fallahi B.,<br />
Fard A., "Efficacy of radioiodine therapy in the treatment of elevated serum<br />
thyroglobuline in patients with differentiated thyroid carcinoma and negative<br />
whole body iodine scan ", World Journal of Nuclear Medicine, 2006; 5<br />
(Suppl 1): S61, (abstract no. 2167). [English]<br />
33. Assadi M., Gholamrezanezhad A., Saghari M., Eftekhari M., Fallahi B., Fard A.,<br />
Beiki D., Akbarpour S., Gholamrezanezhad A., Takavar A., "Comparison<br />
between brain perfusion single photon emission computed tomography and<br />
anatomical imaging in chronic complications of traumatic head injury", World<br />
Journal of Nuclear Medicine, 2006; 5(Suppl 1): S61, (abstract no.<br />
2168). [English]<br />
34. Eftekhari M., Assadi M., Kazemi M., Saghari M., Fard A., Fallahi B.,<br />
Gholamrezanezhad A., Beiki D., Takavar A., "Neurospect evaluation in patients<br />
with post traumatic anosmia; a preliminary study", World Journal of Nuclear<br />
Medicine, 2006; 5(Suppl 1): S62, (abstract no. 2174). [English]<br />
35. Fard A., Gholamrezanezhad A., Eftekhari M., Saghari M., Fallahi B., Beiki D.,<br />
Takavar A., Mirpour S., "Assessment of the Accuracy of lacrimal scintigraphy<br />
based on a prospective analysis of patients symptomatology", World Journal<br />
of Nuclear Medicine, 2006; 5(Suppl 1): S83, (abstract no. 2279).<br />
[English]<br />
36. Beiki D., Dowlatabadi R., "Radiopharmaceutical regulation world wide- the<br />
resemblances and differences", World Journal of Nuclear Medicine, 2006; 5<br />
(Suppl 1): S99, (abstract no. 3035). [English]<br />
37. Mirpour S., Fard A., Gholamrezanezhad A., Eftekhari M., Saghari M., Fallahi B.,<br />
Beiki D., Takavar A., "Quantitative assessment of dacrioscintigraphic images in<br />
the evaluation of epiphora", World Journal of Nuclear Medicine, 2006; 5<br />
(Suppl 1): S106, (abstract no. 3076). [English]<br />
38. Fard A., Fallahi B., Beiki D., Eftekhari M., Saghari M., Takavar A., Ansari K.,"<br />
Myocardial perfusion scan accuracy in detection of coronary artery disease –<br />
comparison with exercise stress test", World Journal of Nuclear Medicine,<br />
2006; 5(Suppl 1): S133, (abstract no. 3216). [English]<br />
39. Fallahi B., Saghari M., Beiki D., Fard A., Eftekhari M., Gholamrezanezhad A.,<br />
"Comparison between three interpretative methods for diagnosis of coronary<br />
artery disease in the territory of left anterior descending artery by dipyridamole<br />
myocardial perfusion imaging in patients with left bundle branch block", World<br />
Journal of Nuclear Medicine, 2006; 5(Suppl 1): S133, (abstract no.<br />
3219). [English]<br />
40. Fallahi B., Beiki D., Akbarpour S., Akhzari F., Izadyar S., Esmaeili J., Eftekhari<br />
M., Fard A., Saghari M., " Discontinuing of long-term beta-blocker therapy may<br />
falsely overestimate the fixed defects in dipyridamole myocardial perfusion<br />
imaging", World Journal of Nuclear Medicine, 2006; 5(Suppl 1): S134,<br />
(abstract no. 3220). [English]<br />
41. Beiki D., Dowlatabadi R., Fallahi B., Eftekhari M., Khalaj A., Fard A., Ansari K.,<br />
"Microdose C-14 urea breath test for the diagnosis of helicobacter pylori",<br />
World Journal of Nuclear Medicine, 2006; 5(Suppl 1): S145, (abstract<br />
no. 3284). [English]<br />
42. Beiki D., Dowlatabadi R., Fallahi B., Eftekhari M., Fard A., Khalaj A., Ansari K.,<br />
"C-13 UBT by non dispersive isotope selected infrared (NDIR) spectroscopy vs<br />
C-14 UBT in diagnosis of HP infection", World Journal of Nuclear Medicine,<br />
2006; 5(Suppl 1): S146, (abstract no. 3285). [English]<br />
43. Ansari K., Fallahi B., Eftekhari M., Fard A., Beiki D., "Changes in gonadal<br />
function in hyperthyroid patients treated with radioiodine", World Journal of<br />
mhtml:file://C:\Documents and Settings\Dr\Desktop\<strong>CV</strong> Davood Beiki.mht<br />
Page 15 of 18<br />
<strong>2008</strong>/05/30
<strong>CV</strong>: Davood Beiki<br />
Nuclear Medicine, 2006; 5(Suppl 1): S157, (abstract no. 3345). [English]<br />
44. Eftekhari M., Noorani M., Beiki D., Saghari M., Fallahi B., Fard A., "Diagnostic<br />
role of Tc-99m Tetrofosmin scintigraphy in cold thyroid nodules", World<br />
Journal of Nuclear Medicine, 2006; 5(Suppl 1): S157, (abstract no.<br />
3349). [English]<br />
45. Eftekhari M., Arabi M., Esmaeili J., Akhzari F., Fallahi B., Beiki D., Saghari M.,<br />
Fard A. Gholamrezanezhad A., "Assessing the diagnostic accuracy of sentinel<br />
lymph nodes lymphoscintigraphy using Tc-99m Phytate in breast cancer",<br />
World Journal of Nuclear Medicine, 2006; 5(Suppl 1): S169, (abstract<br />
no. 3412). [English]<br />
46. Fard-Esfahani A., Mohagheghi A., Assadi M., Fallahi B., Saghari M., Akhzari F.,<br />
Izadyar S., Eftekhari M., Beiki D., Takavar A., Ansari-Gilani K., " The role of<br />
scintigraphic perfusion imaging in the evaluation of patients before and after<br />
percutaneous transluminal coronary angioplasty (PTCA)", Iranian Journal of<br />
Nuclear Medicine, 2006; 14(Suppl 1): 3. [English]<br />
47. Saghari M., Vakili A., Gholamrezanezhad A., Mirpour S., Beiki D., Sadjadi A.,<br />
Farahani M.H., " The long term effects of mustard gas on myocardial perfusion<br />
pattern of intoxicated warfare patients", Iranian Journal of Nuclear<br />
Medicine, 2006; 14(Suppl 1): 10. [English]<br />
48. Saghari M., Eftekhari M., Assadi M., Pourbehi M.R., Fard-Esfahani A., Nasiri M.,<br />
Fallahi B., Beiki D.,Takavar A., Nazarahari M., " The relation between<br />
helicobacter pylori infection and cardiac syndrome X; a preliminary study",<br />
Iranian Journal of Nuclear Medicine, 2006; 14(Suppl 1): 13. [English]<br />
49. Fallahi B., Beiki D., Mahmoudian B., Gholamrezanezhad A., Fard-Esfahani A.,<br />
Eftekhari M., Hozhabrossadati M., " Evaluation of a new mono-phasic imaging<br />
protocol in comparison with conventional dual-phase study of myocardial<br />
perfusion", Iranian Journal of Nuclear Medicine, 2006; 14(Suppl 1): 15.<br />
[English]<br />
50. Fallahi B., Saghari M., Eftekhari M., Fard-Esfahani A., Beiki D., Yamini-Sharif<br />
A., Kamalhedayat D., Gholamrezanezhad A., Sadeghi Sh., Ansari M., Ansari-<br />
Gilani K., " The best pattern of interpretation in dipyridamole myocardial<br />
perfusion scan for diagnosis of coronary artery disease in the territory of left<br />
anterior descending artery in patients with left bundle branch block", Iranian<br />
Journal of Nuclear Medicine, 2006; 14(Suppl 1): 16. [English]<br />
51. Beiki D., Fallahi B., Akbarpour S., Akhzari F., Izadyar S., Esmaeili J., Saghari<br />
M., Eftekhari M., Fard-Esfahani A., “Discontinuing of long-term beta-blocker<br />
therapy may falsely overestimate the fixed defects in dipyridamole myocardial<br />
perfusion imaging”, Iranian Journal of Nuclear Medicine, 2006; 14(Suppl<br />
1): 17. [English]<br />
52. Fard-Esfahani A., Fallahi B., Saghari M., Eftekhari M., Beiki D., Takavar A.,<br />
Ansari-Gilani K., “Accuracy of myocardial perfusion scan in detection of coronary<br />
artery disease- comparison with exercise stress test”, Iranian Journal of<br />
Nuclear Medicine, 2006; 14(Suppl 1): 18. [English]<br />
53. Beiki D., Fallahi B., “Nuclear medicine imaging techniques in the evaluation of<br />
pharmaceutical formulations”, Iranian Journal of Nuclear Medicine, 2006; 14<br />
(Suppl 1): 34. [English]<br />
54. Saghari M., Gholamrezanezhad A., Mirpour S., Fallahi B., Beiki D., Sadjadi A.,<br />
Addollahzadeh J., “On-levothyroxine measurement of thyroglobulin is not a<br />
reliable screening test for patients at high risk of remnant/recurrent<br />
differentiated thyroid carcinoma”, Iranian Journal of Nuclear Medicine,<br />
2006; 14(Suppl 1): 51. [English]<br />
55. Gholamrezanezhad A., Fard A., Sadeghi Tari A., Mirpour S., Fallahi B., Beiki D.,<br />
“Analysis of dacryoscintigraphic images based on a simple quantitative<br />
measure”, Iranian Journal of Nuclear Medicine, 2006; 14(Suppl 1): 56.<br />
[English]<br />
56. Fard A., Saghari M., Gholamrezanezhad A., Mirpour S., Sadjadi A., Fallahi B.,<br />
Beiki D., “Assessment of the accuracy of lacrimal scintigraphy based on a<br />
prospective analysis of patients’ symptomatology”, Iranian Journal of<br />
Nuclear Medicine, 2006; 14(Suppl 1): 57. [English]<br />
57. Eftekhari M., Assadi M., Kazemi M., Saghari M., Fard-Esfahani A., Fallahi B.,<br />
mhtml:file://C:\Documents and Settings\Dr\Desktop\<strong>CV</strong> Davood Beiki.mht<br />
Page 16 of 18<br />
<strong>2008</strong>/05/30
<strong>CV</strong>: Davood Beiki<br />
Takavar A., Gholamrezanezhad A., Beiki D., “NeuroSPECT evaluation in patients<br />
with post-traumatic anosmia, a preliminary study”, Iranian Journal of<br />
Nuclear Medicine, 2006; 14(Suppl 1): 58. [English]<br />
58. Eftekhari M., Saghari M., Assadi M., Fallahi B., Fard-Esfahani A., Takavar A.,<br />
Beiki D., Akbarpour S., Gholamrezanezhad A., Nazarahari M., “Comparison<br />
between brain perfusion single photon emission computed tomography (SPECT)<br />
and anatomical imaging in chronic complications of traumatic head injury”,<br />
Iranian Journal of Nuclear Medicine, 2006; 14(Suppl 1): 59. [English]<br />
59. Fard-Esfahani A., Saghari M., Eftekhari M., Beiki D., Fallahi B., Takavar A.,<br />
Ansari-Gilani K., "Nuclear medicine role in neonatal jaundice", Iranian Journal<br />
of Pediatrics, 2006; 16(Suppl 1): 55. [English]<br />
60. Beiki D., Fard-Esfahani A., Fallahi B., Eftekhari M., Ansari-Gilani K., "Indirect<br />
radionuclide cystography in children", Iranian Journal of Pediatrics, 2006;<br />
16(Suppl 1): 62. [English]<br />
61. Ansari-Gilani K., Beiki D., Fard-Esfahani A., Fallahi B., Eftekhari M., "Renal<br />
cortical scintigraphy in children", Iranian Journal of Pediatrics, 2006; 16<br />
(Suppl 1): 62. [English]<br />
62. Gholamrezanezhad A., Mirpour S., Fard-Esfahani A., Fallahi B., Saghari M.,<br />
Eftekhari M., Beiki D., Soheilifar M., Navid H., "Correlative study comparing<br />
different methods of calculating left ventricular ejection fraction", Journal of<br />
Molecular and Cellular Cardiology, 2006; 40(6): 1015. [English]<br />
63. Fard-Esfahani A., Mirshekarpour H., Fallahi B., Eftekhari M., Saghari M., Beiki<br />
D., Takavar A., "Lacrimal gland function in patients with thyroid cancer treated<br />
with radioactive iodine", Radiotherapy and Oncology 2006 SEP; Suppl. 1<br />
S70 238. [English]<br />
64. Takavar A., Saghari M., Gholamrezanezhad A., Mirpour S., Fallahi B., Fard-<br />
Esfahani Beiki D., Eftekhari M., Sassan S., "Efficacy of Radioiodine therapy in<br />
patients of differentiated thyroid cancer with elevated serum thyroglobulin and<br />
negative I-131 scan ", World Journal of Nuclear Medicine 2007; Vol: 6,<br />
Suppl. 1, 009. [English]<br />
65. Eftekhari M., Assadollahi A., Assadi M., Izadyar S., Fard-Esfahani A., Fallahi B.,<br />
Beiki D., Takavar A., Ansari-Gilani K., "Mineral Density in patients with welldifferentiated<br />
thyroid carcinoma", World Journal of Nuclear Medicine 2007;<br />
Vol: 6, Suppl. 1, 006. [English]<br />
66. Fard-Esfahani A., Mirshekarpour H., Fallahi B., Eftekhari M., Takavar A., Beiki<br />
D., Ansari-Gilani K., Saghari M., "Radioiodine therapy effects on lacrimal gland<br />
function in patients with thyroid cancer", World Journal of Nuclear Medicine<br />
2007; Vol: 6, Suppl. 1, 002. [English]<br />
67. Fard-Esfahani A., Fallahi B., Hadifar M., Beiki D., Eftekhari M., Saghari M.,<br />
Takavar A., "Radioiodine treatment complications in mother and child in patients<br />
with differentiated thyroid carcinoma", Radiotherapy and Oncology 2007<br />
Oct; Vol: 84/2, Suppl. 2: 223. [English]<br />
68. Eftekhari M., M Asadi, Fard-Esfahani A., Beiki D., Fallahi B., M. Yaghoubi, M.,<br />
Saghari M., "Angiographic findings in cardiac syndrome X (CSX) comparing with<br />
myocardial perfusion imaging (MPI) and exercise treadmill test (ETT) ",<br />
European Journal of Nuclear Medicine and Molecular Imaging, 2007; 34<br />
(Suppl 2): S161, (abstract no. 190). [English]<br />
69. Fallahi B., Beiki D., Mousavi A., Gholamrezanezhad A., Ansari Gilani K., Fard-<br />
Esfahani A., S. Mirpour, K. Alimoghaddam, Eftekhari M., "The value of 99mTc- MIBI scintigraphy for the diagnosis of multiple drug resistance in multiple<br />
myeloma patients", European Journal of Nuclear Medicine and Molecular<br />
Imaging, 2007; 34(Suppl 2): S317, (abstract no. p257). [English]<br />
70. Eftekhari M., Asadi M., Fard-Esfahani A., Akbarpor S., Gholamrezanezhad A.,<br />
Fallahi B., Beiki D., Saghari M. "Brain perfusion abnormalities in patients with<br />
chronic symptoms studied with Technetium-99m ethyl cysteinate dimmer<br />
( 99mTc-ECD) more than one year", European Journal of Nuclear Medicine<br />
and Molecular Imaging, 2007; 34(Suppl 2): S327, (abstract no. p312).<br />
[English]<br />
71. Beiki D., Fallahi B., Khalaj A., Rafiee H., Najafi R. "Simple synthesis of<br />
radioiodinated N-succinimidyl-4iodobenzoate: an intermediate compound for the<br />
mhtml:file://C:\Documents and Settings\Dr\Desktop\<strong>CV</strong> Davood Beiki.mht<br />
Page 17 of 18<br />
<strong>2008</strong>/05/30
<strong>CV</strong>: Davood Beiki<br />
indirect radioiodination of antibodies", European Journal of Nuclear Medicine<br />
and Molecular Imaging, 2007; 34(Suppl 2): S330, (abstract no. p327).<br />
[English]<br />
72. Beiki D., Fallahi B., Dadashzadeh S., Shahhosseini S., Eftekhari M., Fard-<br />
Esfahani A. "Hospital discharge policy in patients receiving iodine-131 therapy<br />
for thyroid carcinoma based on monitoring of radiation dose rate and radioiodine<br />
urinary excretion", European Journal of Nuclear Medicine and Molecular<br />
Imaging, 2007; 34(Suppl 2): S355, (abstract no. p458). [English]<br />
73. Zakani A., Saghari M., Eftekhari M., Fard-Esfahani A. Asadi M., Fallahi B., Beiki<br />
D., "Evaluation of radioiodine therapy in differentiated thyroid cancer (DTC) in<br />
patients with negative diagnostic I-131 whole body scans and elevated serum<br />
thyroglobulin levels: a comparison study with thallium scan", European<br />
Journal of Nuclear Medicine and Molecular Imaging, 2007; 34(Suppl 2):<br />
S358, (abstract no. p469). [English]<br />
73. Zakani A., Saghari M., Eftekhari M., Fard-Esfahani A. Asadi M., Fallahi B., Beiki<br />
D., "Evaluation of radioiodine therapy in differentiated thyroid cancer (DTC) in<br />
patients with negative diagnostic I-131 whole body scans and elevated serum<br />
thyroglobulin levels: a comparison study with thallium scan", European<br />
Journal of Nuclear Medicine and Molecular Imaging, 2007; 34(Suppl 2):<br />
S358, (abstract no. p469). [English]<br />
D. Books:<br />
Beiki D., Quality Control of Radiopharmaceuticals. In: Textbook of Nuclear<br />
Pharmacy. 2007; 195-235 [Persian]<br />
E. Media & Software<br />
Title of Media or Software: ParsMedline<br />
Usage: The First Specific Iranian Health and Medical Research Database<br />
Designer(s)/Programmer(s):Dr Omid Beiki, Dr Mohammad Reza Haji esmaili,<br />
Dr Davood Beiki, Ali Shafaat, Amir Bahrami Ahmadi<br />
Year: 2003<br />
Interests<br />
Professional Interests:<br />
Synthesis of radiosensitizers and radioprotectors. Quality control in radiopharmacy. Gammascintigraphy<br />
in the evaluation of pharmaceuticals dosage forms. Hospital radiopharmacy.<br />
Interests:<br />
Mountain climbing, Music<br />
Tehran University of Medical Sciences<br />
mhtml:file://C:\Documents and Settings\Dr\Desktop\<strong>CV</strong> Davood Beiki.mht<br />
Page 18 of 18<br />
<strong>2008</strong>/05/30